William Berry to Biomarkers, Tumor
This is a "connection" page, showing publications William Berry has written about Biomarkers, Tumor.
Connection Strength
0.481
-
Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors. Int J Cancer. 2017 05 15; 140(10):2331-2343.
Score: 0.451
-
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. Int J Cancer. 2018 09 01; 143(5):1162-1175.
Score: 0.030